YWYijun Wang

Yijun Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yijun Wang has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI-driven multi-horizon risk stratification for heart failure hospitalization in UA with HFpEF: a Chinese multi-center cohort study

    by Liying Huang, Yijun Wang, Mengdie Liu, Wenyuan Yin, Yonglian Chen, Tongjian Zhu, Jiajun Zhu, Bowen Zhou, Jun Wang, Jinhui Wu

  • Multivariate Machine Learning Model for Long‐Term Risk Prediction of Acute Coronary Syndrome in Patients With Heart Failure With Preserved Ejection Fraction and Obstructive Sleep Apnea

    by YiJun Wang, Yanan Xu, Jin Peng, Menglei Hao, Liying Huang, Zhuoya Yao, Huaiyu Ruan, Junjie Leng, Wenyuan Yin, Yi Yang, et al.

    Background: Heart failure with preserved ejection fraction is a heterogeneous syndrome, and comorbid obstructive sleep apnea further increases the risk of acute coronary syndrome. However, effective tools for long‐term acute coronary syndrome risk stratification in this population remain limited. This study aimed to develop and externally validate a machine learning‐based prognostic model for predicting acute coronary syndrome risk at multiple time points in patients with heart failure with preserved ejection fraction and obstructive sleep apnea. Methods: We retrospectively enrolled 2272 patients with heart failure with preserved ejection fraction and obstructive sleep apnea from 2 tertiary hospitals. Candidate predictors from clinical characteristics, sleep monitoring, laboratory tests, and echocardiography were selected using least absolute shrinkage and selection operator regression and the Boruta algorithm. Thirty‐three survival models were developed, and the optimal model was selected based on the concordance index and externally validated. Results: Ten core predictors were identified, including metabolic, sleep‐related, and cardiac parameters. The accelerated oblique random survival forest model achieved the best discrimination among all evaluated models, with a concordance index of 0.731 in the external validation cohort. The model demonstrated good time‐dependent discrimination, with area under the curve values of 0.742, 0.734, and 0.755 at 20, 30, and 40 months, respectively. Calibration analyses and decision curve analysis supported its reliability and clinical utility. Conclusions: We developed and externally validated a machine learning‐based model for multitime‐point acute coronary syndrome risk prediction in patients with heart failure with preserved ejection fraction and obstructive sleep apnea. The accelerated oblique random survival forest model, implemented as a web‐based calculator, may facilitate individualized risk assessment and clinical decision‐making. Registration: URL: https://www.chictr.org.cn/ ; Unique Identifier: ChiCTR2300075727.


  • Top Cited Papers

    Large Language Model Agent for Managing Patients With Suspected Hypertension

    by Yijun Wang, Wuping Tan, Siyi Cheng, Chen Peng, Jin Peng, Fanglin Qin, Long Tang, Tongjian Zhu, Bing Wu, Jinjun Liu, et al.

    BACKGROUND: The effectiveness of Large Language Model agent frameworks for hypertension screening and personalized health management has not been fully studied. This study aimed to develop and evaluate a Large Language Model–based Agent, called the Cascade Framework, and assess its effectiveness in hypertension education and clinical decision support. METHODS: The Cascade Framework was developed utilizing the Dify platform, and its performance was tested via a robust 2-phase evaluation protocol from August 2024 to June 2025. The first phase involved systematic performance benchmarking of 6 configurations: 3 foundational Large Language Models (Chat Generative Pretrained Transformer [ChatGPT]-4o, ChatGPT-4oMini, and DeepSeek-V3) and their respective Cascade-enhanced versions. The second phase included an external validation in a cohort of patients with suspected hypertension. RESULTS: Cascade integration yielded significant performance improvements across all models. For ChatGPT-4o, educational outcomes improved (Accuracy: 3.87→4.10, P =0.02; Comprehensiveness: 4.07→4.32, P =0.16; Credibility: 3.79→4.03, P P =0.005; Emotional Support: 3.87→4.01, P P P P <0.001 and surpassing the performance of the 3 physicians. CONCLUSIONS: Cascade Framework can improve the management of hypertension. Its extensible architecture allows integration with existing clinical workflows while providing transparent reasoning pathways.


  • Open Access

    Multimodal Data–Driven Explainable Prognostic Model for Major Adverse Cardiovascular Events Prediction in Patients With Unstable Angina and Heart Failure With Preserved Ejection Fraction: Multicenter, Cross-Regional Cohort Study

    by Yijun Wang, Yaoling Wang, Yujie Luan, Menglei Hao, Wenyuan Yin, Bing Wu, Tongjian Zhu, Jiajun Zhu, Bowen Zhou, Long Tang, et al.

    Background: Heart failure with preserved ejection fraction (HFpEF) and unstable angina (UA) often coexist in clinical practice, constituting a high-risk cardiovascular phenotype with a markedly increased incidence of major adverse cardiovascular events (MACEs). The identification of high-risk patients within this population is crucial for reducing complications, improving outcomes, and guiding clinical decision-making. Objective: This study aimed to develop and externally validate predictive models based on machine learning algorithms to estimate the risk of MACEs in patients with coexisting UA and HFpEF, and to construct an online risk calculator to support individualized prevention strategies. Methods: This multicenter cohort study included 4459 patients with both HFpEF and UA admitted to 7 hospitals across eastern, central, and western China between January 1, 2015, and December 31, 2021. Patients were divided into the derivation cohort (n=2923) and external validation cohort (n=1536) based on geographic regions. Clinical, laboratory, and imaging data were extracted from electronic medical records. Key predictors were identified using a hybrid feature selection method combining least absolute shrinkage and selection operator and Boruta algorithms. A total of 33 survival models were developed, including a variety of machine learning algorithms and survival analysis models. The model with the best concordance index (C-index) performance was deployed as a web-based risk calculator. Additionally, we assessed other performance indicators of the best-performing model, including the area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, recall, F 1 -score, Brier scores, calibration curves, and decision curve analysis. Results: Using a combination of the least absolute shrinkage and selection operator regression and the Boruta algorithm, 7 key predictors were identified: diabetes mellitus, blood platelet count, triglyceride, systemic inflammatory response index, triglyceride-glucose–BMI, N-terminal pro-brain natriuretic peptide, and atherogenic index of plasma. The surv.xgboost.cox model was used to predict MACEs in patients with UA and HFpEF due to its superior C-index. The model demonstrated the following performance metrics in the external validation cohort: a C-index of 0.788; cumulative/dynamic area under the curve of 0.81; and area under the curve values at 20, 30, and 40 months of 0.809 (95% CI 0.745‐0.873), 0.784 (95% CI 0.745‐0.824), and 0.807 (95% CI 0.776‐0.838), respectively. The model exhibited satisfactory calibration and clinical utility in predicting 40-month MACEs. Model interpretability was enhanced using Shapley Additive Explanations for survival analysis to provide global and individual explanations. Furthermore, we converted the surv.xgboost.cox-based model into a publicly available tool for predicting 40-month MACEs, providing estimated probabilities based on the predictive indicators entered. Conclusions: We developed a surv.xgboost.cox-based predictive model for MACEs in patients with the dual phenotype of HFpEF and UA. We implemented this model as a web-based calculator to facilitate clinical application.


  • Open Access

    The Effectiveness of Digital Animation–Based Multistage Education for Patients With Atrial Fibrillation Catheter Ablation: Randomized Clinical Trial

    by Xiaoyu Shi, Yijun Wang, Yuhong Wang, Jun Wang, Chen Peng, Siyi Cheng, Lingpeng Song, Rui Li, Fuding Guo, Zeyan Li, et al.

    Background: Digital education for outpatient patients with atrial fibrillation (AF) has gradually increased. However, research on digital education for patients undergoing atrial fibrillation catheter ablation (AFCA) is limited. Objective: This study aimed to develop a novel digital animation-based multistage education system and evaluate its quality-of-life benefits for patients with AFCA. Methods: This randomized controlled clinical trial included 208 patients with AF who underwent catheter ablation in the Department of Cardiology at Renmin Hospital of Wuhan University between January 2022 and August 2023. The patients were randomly assigned to the digital animation intervention (n=104) and standard treatment (n=104) groups. The primary outcome was the difference in the quality of life of patients with atrial fibrillation (AF-QoL-18) scores at 3 months. Secondary outcomes included differences in scores on the 5-item Medication Adherence Report Scale (MARS-5), Self-rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS) at 3 months. Results: In the digital animation intervention group, the AF-QoL-18 score increased from 38.02 (SD 6.52) to 47.77 (SD 5.74), the MARS-5 score increased from 17.04 (SD 3.03) to 20.13 (SD 2.12), the SAS score decreased from 52.82 (SD 8.08) to 45.39 (SD 6.13), and the SDS score decreased from 54.12 (SD 6.13) to 45.47 (SD 5.94), 3 months post discharge from the hospital. In the conventional treatment group, the AF-QoL-18 score increased from 36.97 (SD 7.00) to 45.31 (SD 5.71), the MARS-5 score increased from 17.14 (SD 3.01) to 18.47 (SD 2.79), the SAS score decreased from 51.83 (SD 7.74) to 47.31 (SD 5.87), and the SDS score decreased from 52.78 (SD 5.21) to 45.37 (SD 6.18). The mean difference in AF-QoL-18 score change between the 2 groups was 1.41 (95% CI 2.42-0.40, P=.006) at 3 months. The mean difference in MARS-5 score change was 1.76 (95% CI 2.42-1.10, P<.001). The mean difference in SAS score was –2.91 (95% CI –3.88 to –1.95, P<.001). Additionally, the mean difference in SDS score was –1.23 (95% CI –0.02 to –2.44, P=.047). Conclusions: Our study introduces a novel digital animation educational approach that provides multidimensional, easily understandable, and multistage education for patients with AF undergoing catheter ablation. This educational model effectively improves postoperative anxiety, depression, medication adherence, and quality of life in patients at 3 months post discharge. Trial Registration: Chinese Clinical Trial Registry ChiCTR2400081673; https://www.chictr.org.cn/showproj.html?proj=201059


  • Open Access

    Multimodal Data‐Driven Prognostic Model for Predicting Long‐Term Prognosis in Patients With Ischemic Cardiomyopathy and Heart Failure With Preserved Ejection Fraction After Coronary Artery Bypass Grafting: A Multicenter Cohort Study

    by Jun Wang, Yijun Wang, Shoupeng Duan, Li Xu, Yanan Xu, Wenyuan Yin, Yi Yang, Bing Wu, Jinjun Liu

    Background: Limited data from the literature are available to assess the efficacy of coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction. Therefore, our objective was to use machine learning techniques integrating clinical features, biomarker data, and echocardiography data to enhance comprehension and risk stratification in patients diagnosed with ischemic cardiomyopathy and heart failure with preserved ejection fraction who have undergone coronary artery bypass grafting surgery. Methods and Results: For this study, 294 patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction who underwent coronary artery bypass grafting surgery were assigned to the development cohort (n=176) and the independent validation cohort (n=118). A total of 52 clinical variables were extracted for each patient. The principal clinical end point was the incidence of major adverse cardiovascular events, encompassing cardiac mortality, acute myocardial infarction, acute heart failure, and graft failure. From least absolute shrinkage and selection operator regression, 4 predictors were selected for the final prediction nomogram: diabetes, hypertension, the systemic immune‐inflammation index, and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide). The prediction nomogram achieved satisfactory prediction performance in both the development cohort (C index, 0.768 [95% CI, 0.701–0.835]) and independent validation cohort (C index, 0.633 [95% CI, 0.521–0.745]). Adequate calibration was noted for the likelihood of major adverse cardiovascular events in both the development and independent validation cohorts. Decision curve analysis confirmed the clinical usefulness of the established prediction nomogram. Conclusions: A clinically feasible prognostic model, based on preoperative multimodal data, was developed for risk stratification of patients with ischemic heart and heart failure with preserved ejection fraction who receive coronary artery bypass grafting surgery. Registration: https://www.chictr.org.cn ; Unique identifier: ChiCTR2300074439.


  • Open Access

    The Effectiveness of Digital Animation–Based Multistage Education for Patients With Atrial Fibrillation Catheter Ablation: Randomized Clinical Trial (Preprint)

    by Xiaoyu Shi, Yijun Wang, Yuhong Wang, Jun Wang, Chen Peng, Siyi Cheng, Lingpeng Song, Rui Li, Fuding Guo, Zeyan Li, et al.

    BACKGROUND Digital education for outpatient patients with atrial fibrillation (AF) has gradually increased. However, research on digital education for patients undergoing atrial fibrillation catheter ablation (AFCA) is limited. OBJECTIVE This study aimed to develop a novel digital animation-based multistage education system and evaluate its quality-of-life benefits for patients with AFCA. METHODS This randomized controlled clinical trial included 208 patients with AF who underwent catheter ablation in the Department of Cardiology at Renmin Hospital of Wuhan University between January 2022 and August 2023. The patients were randomly assigned to the digital animation intervention (n=104) and standard treatment (n=104) groups. The primary outcome was the difference in the quality of life of patients with atrial fibrillation (AF-QoL-18) scores at 3 months. Secondary outcomes included differences in scores on the 5-item Medication Adherence Report Scale (MARS-5), Self-rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS) at 3 months. RESULTS In the digital animation intervention group, the AF-QoL-18 score increased from 38.02 (SD 6.52) to 47.77 (SD 5.74), the MARS-5 score increased from 17.04 (SD 3.03) to 20.13 (SD 2.12), the SAS score decreased from 52.82 (SD 8.08) to 45.39 (SD 6.13), and the SDS score decreased from 54.12 (SD 6.13) to 45.47 (SD 5.94), 3 months post discharge from the hospital. In the conventional treatment group, the AF-QoL-18 score increased from 36.97 (SD 7.00) to 45.31 (SD 5.71), the MARS-5 score increased from 17.14 (SD 3.01) to 18.47 (SD 2.79), the SAS score decreased from 51.83 (SD 7.74) to 47.31 (SD 5.87), and the SDS score decreased from 52.78 (SD 5.21) to 45.37 (SD 6.18). The mean difference in AF-QoL-18 score change between the 2 groups was 1.41 (95% CI 2.42-0.40, P=.006) at 3 months. The mean difference in MARS-5 score change was 1.76 (95% CI 2.42-1.10, P<.001). The mean difference in SAS score was –2.91 (95% CI –3.88 to –1.95, P<.001). Additionally, the mean difference in SDS score was –1.23 (95% CI –0.02 to –2.44, P=.047). CONCLUSIONS Our study introduces a novel digital animation educational approach that provides multidimensional, easily understandable, and multistage education for patients with AF undergoing catheter ablation. This educational model effectively improves postoperative anxiety, depression, medication adherence, and quality of life in patients at 3 months post discharge. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2400081673; https://www.chictr.org.cn/showproj.html?proj=201059

  • Open Access

    Multimodal data integration for enhanced longitudinal prediction for cardiac and cerebrovascular events following initial diagnosis of obstructive sleep apnea syndrome

    by Tong Zhou, Yijun Wang, Yanan Xu, Li Xu, Long Tang, Yi Yang, Jun Wang

    Obstructive sleep apnea syndrome (OSAS) is a serious health condition that can negatively impact individuals’ overall well-being, especially accelerated atherosclerosis and increased cardiovascular disease risk [1–3]. Early detection and intervention of OSAS have been shown to significantly improve clinical outcomes and enhance sleep-related quality of life [1–3]. Thus, the promotion of public awareness regarding OSAS […]


  • Open Access

    Efficacy of a WeChat-Based Multimodal Digital Transformation Management Model in New-Onset Mild to Moderate Hypertension: Randomized Clinical Trial

    by Yijun Wang, Fuding Guo, Jun Wang, Zeyan Li, Wuping Tan, Mengjie Xie, Xiaomeng Yang, Shoupeng Duan, Lingpeng Song, Siyi Cheng, et al.

    Background: The advantages of multimodal digitally transformed mobile health management for patients diagnosed with mild to moderate hypertension are not yet established. Objective: We aim to evaluate the therapeutic benefits of a novel WeChat-based multimodal digital transforming management model in mobile health blood pressure (BP) management. Methods: This randomized controlled clinical trial included 175 individuals with new-onset mild to moderate hypertension who were admitted to our center between September and October 2022. The patients were randomly assigned to either the multimodal intervention group (n=88) or the usual care group (n=87). The primary composite outcome was home and office BP differences after 6 months. The major secondary outcomes were 6-month quality-of-life scores, including the self-rating anxiety scale, self-rating depression scale, and Pittsburgh Sleep Quality Index. Results: The mean home BP decreased from 151.74 (SD 8.02)/94.22 (SD 9.32) to 126.19 (SD 8.45)/82.28 (SD 9.26) mm Hg in the multimodal intervention group and from 150.78 (SD 7.87)/91.53 (SD 9.78) to 133.48 (SD 10.86)/84.45 (SD 9.19) mm Hg in the usual care group, with a mean difference in systolic blood pressure and diastolic blood pressure of –8.25 mm Hg (95% CI –11.71 to –4.78 mm Hg; P<.001) and –4.85 mm Hg (95% CI –8.41 to –1.30 mm Hg; P=.008), respectively. The mean office BP decreased from 153.64 (SD 8.39)/93.56 (SD 8.45) to 127.81 (SD 8.04)/ 82.16 (SD 8.06) mm Hg in the multimodal intervention group and from 151.48 (SD 7.14)/(91.31 (SD 9.61) to 134.92 (SD 10.11)/85.09 (SD 8.26) mm Hg in the usual care group, with a mean difference in systolic blood pressure and diastolic blood pressure of –9.27 mm Hg (95% CI –12.62 to –5.91 mm Hg; P<.001) and –5.18 mm Hg (95% CI –8.47 to –1.89 mm Hg; P=.002), respectively. From baseline to 6 months, home BP control <140/90 mm Hg was achieved in 64 (72.7%) patients in the multimodal intervention group and 46 (52.9%) patients in the usual care group (P=.007). Meanwhile, home BP control <130/80 mm Hg was achieved in 32 (36.4%) patients in the multimodal intervention group and 16 (18.4%) patients in the usual care group (P=.008). After 6 months, there were significant differences in the quality-of-life total and graded scores, including self-rating anxiety scale scores (P=.04), self-rating depression scale scores (P=.03), and Pittsburgh Sleep Quality Index scores (P<.001), in the multimodal intervention group compared with the usual care group. Conclusions: The WeChat-based multimodal intervention model improved the BP control rates and lowered the BP levels more than the usual care approach. The multimodal digital transforming management model for hypertension represents an emerging medical practice that utilizes the individual’s various risk factor profiles for primary care and personalized therapy decision-making in patients with hypertension. Trial Registration: Chinese Clinical Trial Registry ChiCTR2200063550; https://www.chictr.org.cn/showproj.html?proj=175816


  • [Surgical technique of lateral unicompartmental knee arthroplasty and discussion of the maximum correction value in the treatment of knee valgus deformity].

    by Xin Liu, Kai Zheng, Feng Zhu, Yijun Wang, Lianfang Zhang, Weicheng Zhang, Dechun Geng, Jun Zhou, Yaozeng Xu

    To investigate the surgical technique and the short-term effectivenss of lateral unicompartmental knee arthroplasty (LUKA) through lateral approach in the treatment of valgus knee and to calculate the maximum value of the theoretical correction of knee valgus deformity. A retrospective analysis was performed on 16 patients (20 knees) who underwent LUKA and met the selection criteria between April 2021 and July 2022. There were 2 males and 14 females, aged 57-85 years (mean, 71.5 years). The disease duration ranged from 1 to 18 years, with an average of 11.9 years. Knee valgus was staged according to Ranawat classification, there were 6 knees of type Ⅰ, 13 knees of type Ⅱ, and 1 knee of type Ⅲ. All patients were assigned the expected correction value of genu valgus deformity by preoperative planning, including the correction value of lateral approach, intra-articular correction value, and residual knee valgus deformity value. The actual postoperative corrected values of the above indicators were recorded and the theoretical maximum correctable knee valgus deformity values were extrapolated. The operation time, intraoperative blood loss, incision length, hospital stay, hip-knee-ankle angle (HKA), mechanical lateral distal femoral angle (mLDFA), mechanical medial proximal tibia angle (mMPTA), joint line convergence angle (JLCA), posterior tibial slope (PTS), range of motion (ROM), Hospital for Special Surgery (HSS) score, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score were also recorded for effectiveness evaluation. The patients' incision length averaged 13.83 cm, operation time averaged 85.8 minutes, intraoperative blood loss averaged 74.9 mL, and hospital stay averaged 6.7 days. None of the patients suffered any significant intraoperative neurological or vascular injuries. All patients were followed up 10-27 months, with a mean of 17.9 months. One patient with bilateral knee valgus deformities had intra-articular infection in the left knee at 1 month after operation and the remaining patients had no complication such as prosthesis loosening, dislocation, and infection. The ROM, HSS score, and WOMAC score of knee joint significantly improved at each time point after operation when compared to those before operation, and the indicators further improved with time after operation, the differences were all significant ( PP0.05). Postoperative evaluation of the knee valgus deformity correction values showed that the actual intra-articular correction values ranged from 0.54° to 10.97°, with a mean of 3.84°. The postoperative residual knee valgus deformity values ranged from 0.42° to 5.30°, with a mean of 3.59°. The actual correction values of lateral approach ranged from 0.21° to 12.73°, with a mean of 4.26°. LUKA through lateral approach for knee valgus deformity can achieve good early effectiveness. Preoperative planning can help surgeons rationally allocate the correction value of knee valgus deformity, provide corresponding treatment strategies, and the maximum theoretical correction value of knee valgus deformity can reach 25°.